At a compound annual growth rate (CAGR) of 16.7%, the stem cell therapies market is expected to grow from US$ 187 million in 2021 to US$ 401 million by 2026 at a CAGR of 16.7%, by 2032. The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be …